KR890007077A - Atlv항체의 측정시약 및 측정방법 - Google Patents

Atlv항체의 측정시약 및 측정방법 Download PDF

Info

Publication number
KR890007077A
KR890007077A KR1019880014025A KR880014025A KR890007077A KR 890007077 A KR890007077 A KR 890007077A KR 1019880014025 A KR1019880014025 A KR 1019880014025A KR 880014025 A KR880014025 A KR 880014025A KR 890007077 A KR890007077 A KR 890007077A
Authority
KR
South Korea
Prior art keywords
atlv
antigen
reagent
atl
antibody
Prior art date
Application number
KR1019880014025A
Other languages
English (en)
Other versions
KR910004213B1 (ko
Inventor
다까시 사와다
준이찌 도오마쯔
이사오 미요시
히로구니 다구찌
Original Assignee
나이또오 하루오
에자이 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 나이또오 하루오, 에자이 가부시끼가이샤 filed Critical 나이또오 하루오
Publication of KR890007077A publication Critical patent/KR890007077A/ko
Application granted granted Critical
Publication of KR910004213B1 publication Critical patent/KR910004213B1/ko

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/548—Carbohydrates, e.g. dextran
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

내용 없음

Description

ATLV항체의 측정시약 및 측정방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (7)

  1. ATL-관련항원을 이용한 피검시료중의 ATLV항체를 판정하는 측정시약으로서, 상기 ATL-관련항원의 전사 니트로셀룰로스막과 ATLV항원을 필수 요소로서 함유한 것을 특징으로 하는 ATLV항체의 측정시약.
  2. 제1항에 있어서, 상기 ATL-관련항원은 MT-2세포내에서 유래된 것을 특징으로 하는 ATLV항체의 측정시약.
  3. 제1항 또는 2항에 있어서, 상기 ATLV항원은 MT-2세포내에서 유래된 것을 특징으로 하는 ATLV항체의 측정시약.
  4. ATL-관련항원을 이용하여 피검시료중의 ATLV항체를 판정하는 측정방법으로서, 상기 ATL-관련항원의 전사 니트로셀룰로스막을 피검시료와 상기 피검시료에 ATLV항원을 첨가하여 제조한 흡수시료에 각각 첨가하고 그렇게 하여 출현된 각각의 밴드를 대비하는 것을 특징으로 하는 ATLV항체의 측정시약.
  5. 제4항에 있어서, 상기 밴드가 SDS/폴리아클릴아미드 겔 전기영동에 의하여 분자량이 32,000달톤, 28,000달톤, 24,000달톤, 19,000달톤으로 결정되는 단백질 항원에 상응하는 밴드로부터 채택된 두개 또는 그 이상의 밴드의 조합인 것을 특징으로 하는 ATLV항체의 측정방법.
  6. 제4항 또는 5항에 있어서, 상기 ATL-관련항원이 MT-2세포로부터 유래된 것을 특징으로 하는 ATLV항체의 측정방법.
  7. 제4항 내지 6항중 어느 한 항에 있어서, 상기 ATLV항원이 MT-2세포로부터 유래된 것을 특징으로 하는 ATLV항체의 측정방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880014025A 1987-10-28 1988-10-27 Atlv 항체의 측정시약 및 측정방법 KR910004213B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP62272035A JPH01113663A (ja) 1987-10-28 1987-10-28 Ａｔｌｖ抗体の測定試薬および測定方法
JP87-272035 1987-10-28
JP62-272035 1987-10-28

Publications (2)

Publication Number Publication Date
KR890007077A true KR890007077A (ko) 1989-06-17
KR910004213B1 KR910004213B1 (ko) 1991-06-24

Family

ID=17508217

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880014025A KR910004213B1 (ko) 1987-10-28 1988-10-27 Atlv 항체의 측정시약 및 측정방법

Country Status (5)

Country Link
EP (1) EP0314066A3 (ko)
JP (1) JPH01113663A (ko)
KR (1) KR910004213B1 (ko)
DK (1) DK596988A (ko)
NO (1) NO884757L (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU637097B2 (en) * 1989-05-09 1993-05-20 Abbott Laboratories Process for preparing an improved western blot immunoassay

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ228756A (en) * 1984-04-23 1990-10-26 Us Health Detection of hiv antigen using competition immune assay or western blot assay
JPS60249058A (ja) * 1984-05-25 1985-12-09 Eisai Co Ltd Ａｔｌウイルス抗体の測定方法および試薬
DE3422487A1 (de) * 1984-06-16 1985-12-19 Otto Dr. Hard Voradelberg Zimmermann Rotationskolbenmaschine
JPH0762034B2 (ja) * 1984-10-05 1995-07-05 富士レビオ株式会社 Ａｔｌｖ抗原活性を有する蛋白及びその製造法
CA1340878C (en) * 1984-10-26 2000-01-25 Takis S. Papas Production of human t-cell leukemia (lymphotropic) retrovirus (htlv-i) envelope protein fragments in bacteria and use in seroepidemiological survey of human lymphoid malignancies

Also Published As

Publication number Publication date
EP0314066A3 (en) 1990-08-16
DK596988D0 (da) 1988-10-27
JPH01113663A (ja) 1989-05-02
NO884757D0 (no) 1988-10-26
DK596988A (da) 1989-04-29
KR910004213B1 (ko) 1991-06-24
NO884757L (no) 1989-05-02
EP0314066A2 (en) 1989-05-03

Similar Documents

Publication Publication Date Title
ES414618A1 (es) Procedimiento mejorado para la deteccion y determinacion de haptenos.
EP0752426A3 (de) Synthetische Kalibratoren für den Einsatz in Immunoassays, bestehend aus Analyten oder Teilsequenzen davon, die an inerte Trägermoleküle konjugiert sind
FI891012A (fi) Menetelmä ja väline immuunikokeissa esiintyvien häiriötekijöiden kompensoimiseksi
SE7602134L (sv) Diagnostiskt medel for pavisande av eggvita i kroppsvetskor
KR830010384A (ko) 항원 항체 반응의 측정 방법 및 그 시약
ATA100080A (de) Pruefmittel zur bestimmung von glucose
NO950426L (no) Analyse for bestemmelse av protein i en biologisk pröve
KR890702039A (ko) 1,25-디하이드록시 비타민 d의 분석 방법
ES2131708T3 (es) Utilizacion de la electroforesis capilar para determinar la cantidad de concentracion de componentes de proteina y la totalidad de proteina en los fluidos.
DE3781374D1 (de) Fakultatives herausbringen von testmustern.
ATE210827T1 (de) Synthetischer standard für immunoassays
DE68905313D1 (de) Enzym-immunoassay zur messung des cyclosporin-a-spiegels in vollblut-proben.
DE69928507D1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
ATE18920T1 (de) Radioimmunoassay fuer fibrinopeptid a.
KR850002385A (ko) PIVKA-Ⅱ의 측정(assay)용 방법 및 시약
ES2023868B3 (es) Procedimiento de determinacion inmunometrico
ES520777A0 (es) Procedimiento de inmunoanalisis homogeneo para determinar un analito en una muestra de ensayo.
DK199783A (da) Immunoglobulin-halvmolekyler og fremgangsmaade til fremstilling af hybrid-antistoffer
KR890007077A (ko) Atlv항체의 측정시약 및 측정방법
ATE67603T1 (de) Zusammensetzungen zum immunoenzymatischen test von prostaglandinen.
IT1114891B (it) Metodo e corredo di prova per la determinazione di amilasi nel siero
DE69610679D1 (de) Antigen für Enzymimmuntest und Verfahren zur Messung von erythrozytären Antikörpern
KR850003169A (ko) 염기성 태아단백질의 측정방법 및 시약
ES2076221T3 (es) Derivados geminales de difenilo y su uso en inmunoensayos.
DE59207717D1 (de) Verfahren zur Bestimmung einer immunologisch bindefähigen Substanz

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19970617

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee